BioSpace News Archive

BioCapital

Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability

Lonza announces the launch of DonorPlex™ Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind to be produced using Lonza’s novel patented manufacturing process.

February 11, 2019

·

3 min read

Business

Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director

Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announced the appointment of Professor Rajesh Chopra as Non-Executive Director (NED).

February 11, 2019

·

3 min read

BioMidwest

Opioid Perspectives for Government Payers Reveals a Road Map for Addressing National Crisis

The opioid epidemic has become one of the more severe crises of the modern era.

February 11, 2019

·

2 min read

Business

Medidata and Cognizant Form Strategic Alliance to Make Digital Transformation Accessible for the Life Sciences

Turnkey solutions will accelerate and optimize operational aspects of a clinical trial by bringing together industry-leading life science software with world-class managed services

February 11, 2019

·

3 min read

Creative Diagnostics Announces Mycotoxins Analysis for Researchers

As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics today announced the launch of a series of new, innovative mycotoxins analysis products and services for customers globally.

February 11, 2019

·

2 min read

Business

Invitrocue creates Joint Venture with A*STAR scientist Dr. Chen Qingfeng

Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue, a joint venture (JV) between Invitrocue and A*STAR scientist Dr. Chen Qingfeng. Invitrocue will own 70% of the Company, while Dr Chen will own 30%.

February 11, 2019

·

3 min read

New ‘Trojan horse’ cancer treatment shows early promise in multiple tumour types

A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumour cells has shown promise in patients with six different cancer types.

February 11, 2019

·

5 min read

Positive T-Track® CMV Study Results With New Guidance Strategies For Anti-viral Treatment Decisions Following Stem Cell Transplantation

Lophius Biosciences GmbH today announced successful top-line results from its multicenter AlloProtect CMV clinical study.

February 11, 2019

·

4 min read

Drug Development

Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Continued Survival Benefit at 30-Month Follow-up in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Bristol-Myers Squibb Company announced new results from the Phase 3 CheckMate -214 study, showing that therapy with Opdivo plus low-dose Yervoy continued to demonstrate long-term survival benefits in patients with previously untreated advanced or metastatic renal cell carcinoma.

February 11, 2019

·

35 min read

Pharm Country

Merck Highlights Breadth of Immuno-Oncology Research Program in Genitourinary Cancers at ASCO GU

First-Time Data from Pivotal Phase 3 KEYNOTE-426 Trial Showing KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) Significantly Improved OS, PFS and ORR Compared to Sunitinib Monotherapy in First-Line Treatment of Advanced Renal Cell Carcinoma

February 11, 2019

·

39 min read